Dr. Spencer Nadolsky @DrNadolsky · 27 Jul 2026
The peptides (other than fda approved) should stay on the grey market. The harm reduction argument is not strong. Let people decide if they want to risk it. Allow private companies to vet the purity of the companies out there.
9 228Views
54Likes
3Reposts
15Replies
0Quotes
4Bookmarks
Is that a lot?
0.66×vs this author's median13 911 views is typical
25Percentile for this authorof 8 recent posts
2.94×vs 10K–100K median3 137 views is typical
15.05%Reachviews ÷ followers
0.78%Engagement rateof viewers reacted